nodes	percent_of_prediction	percent_of_DWPC	metapath
Trazodone—ORM1—bile—Crohn's disease	0.059	0.227	CbGeAlD
Trazodone—HTR2A—enteric nervous system—Crohn's disease	0.0506	0.195	CbGeAlD
Trazodone—HTR2A—myenteric nerve plexus—Crohn's disease	0.0384	0.148	CbGeAlD
Trazodone—Gastrointestinal discomfort—Azathioprine—Crohn's disease	0.0283	0.0512	CcSEcCtD
Trazodone—ORM1—gall bladder—Crohn's disease	0.0164	0.0631	CbGeAlD
Trazodone—Cholestasis—Mercaptopurine—Crohn's disease	0.0142	0.0257	CcSEcCtD
Trazodone—Ache—Mesalazine—Crohn's disease	0.0127	0.0229	CcSEcCtD
Trazodone—Amylase increased—Mesalazine—Crohn's disease	0.0123	0.0222	CcSEcCtD
Trazodone—Micturition urgency—Mesalazine—Crohn's disease	0.0103	0.0187	CcSEcCtD
Trazodone—Hirsutism—Mesalazine—Crohn's disease	0.0101	0.0182	CcSEcCtD
Trazodone—Psoriasis—Mesalazine—Crohn's disease	0.00932	0.0169	CcSEcCtD
Trazodone—Cholestasis—Azathioprine—Crohn's disease	0.00846	0.0153	CcSEcCtD
Trazodone—Cholestasis—Mesalazine—Crohn's disease	0.00771	0.0139	CcSEcCtD
Trazodone—Jaundice cholestatic—Azathioprine—Crohn's disease	0.00732	0.0132	CcSEcCtD
Trazodone—HTR2B—smooth muscle tissue—Crohn's disease	0.00689	0.0266	CbGeAlD
Trazodone—HTR2B—skin of body—Crohn's disease	0.0068	0.0262	CbGeAlD
Trazodone—Vasodilation—Mesalazine—Crohn's disease	0.00666	0.0121	CcSEcCtD
Trazodone—Jaundice cholestatic—Mesalazine—Crohn's disease	0.00666	0.0121	CcSEcCtD
Trazodone—Vasodilation procedure—Mesalazine—Crohn's disease	0.00666	0.0121	CcSEcCtD
Trazodone—Vasculitis—Azathioprine—Crohn's disease	0.00659	0.0119	CcSEcCtD
Trazodone—Musculoskeletal stiffness—Mesalazine—Crohn's disease	0.00653	0.0118	CcSEcCtD
Trazodone—Leukocytosis—Mesalazine—Crohn's disease	0.00623	0.0113	CcSEcCtD
Trazodone—ADRA1A—epithelium—Crohn's disease	0.00591	0.0228	CbGeAlD
Trazodone—Abnormal dreams—Mesalazine—Crohn's disease	0.00579	0.0105	CcSEcCtD
Trazodone—Menstruation irregular—Prednisone—Crohn's disease	0.0056	0.0101	CcSEcCtD
Trazodone—SLC6A4—digestive system—Crohn's disease	0.00549	0.0212	CbGeAlD
Trazodone—HTR2B—digestive system—Crohn's disease	0.00544	0.021	CbGeAlD
Trazodone—Dry eye—Mesalazine—Crohn's disease	0.00541	0.00978	CcSEcCtD
Trazodone—Hirsutism—Prednisone—Crohn's disease	0.00533	0.00964	CcSEcCtD
Trazodone—Bladder pain—Mesalazine—Crohn's disease	0.00529	0.00958	CcSEcCtD
Trazodone—Photosensitivity—Mesalazine—Crohn's disease	0.00484	0.00876	CcSEcCtD
Trazodone—Alopecia—Mercaptopurine—Crohn's disease	0.00479	0.00866	CcSEcCtD
Trazodone—Disorientation—Mesalazine—Crohn's disease	0.00475	0.0086	CcSEcCtD
Trazodone—Deafness—Mesalazine—Crohn's disease	0.00475	0.0086	CcSEcCtD
Trazodone—Eye pain—Mesalazine—Crohn's disease	0.00471	0.00852	CcSEcCtD
Trazodone—Libido decreased—Mesalazine—Crohn's disease	0.00458	0.00829	CcSEcCtD
Trazodone—HRH1—epithelium—Crohn's disease	0.00457	0.0176	CbGeAlD
Trazodone—ADRA1A—lymphoid tissue—Crohn's disease	0.00455	0.0175	CbGeAlD
Trazodone—Increased appetite—Mesalazine—Crohn's disease	0.00452	0.00818	CcSEcCtD
Trazodone—Atrial fibrillation—Mesalazine—Crohn's disease	0.00449	0.00811	CcSEcCtD
Trazodone—HRH1—smooth muscle tissue—Crohn's disease	0.00441	0.017	CbGeAlD
Trazodone—Delusion—Prednisone—Crohn's disease	0.00438	0.00792	CcSEcCtD
Trazodone—Anaemia—Mercaptopurine—Crohn's disease	0.00436	0.00789	CcSEcCtD
Trazodone—Lethargy—Mesalazine—Crohn's disease	0.00434	0.00785	CcSEcCtD
Trazodone—Disturbance in sexual arousal—Mesalazine—Crohn's disease	0.00422	0.00763	CcSEcCtD
Trazodone—Migraine—Mesalazine—Crohn's disease	0.00418	0.00757	CcSEcCtD
Trazodone—Arthralgia—Mercaptopurine—Crohn's disease	0.00402	0.00726	CcSEcCtD
Trazodone—HRH1—mammalian vulva—Crohn's disease	0.00397	0.0153	CbGeAlD
Trazodone—Memory impairment—Prednisone—Crohn's disease	0.00395	0.00714	CcSEcCtD
Trazodone—ADRA2A—mammalian vulva—Crohn's disease	0.0039	0.015	CbGeAlD
Trazodone—Orthostatic hypotension—Mesalazine—Crohn's disease	0.00388	0.00702	CcSEcCtD
Trazodone—Abdominal discomfort—Azathioprine—Crohn's disease	0.00387	0.00699	CcSEcCtD
Trazodone—Oedema—Mercaptopurine—Crohn's disease	0.00385	0.00696	CcSEcCtD
Trazodone—HTR2A—epithelium—Crohn's disease	0.00382	0.0147	CbGeAlD
Trazodone—ORM1—lymph node—Crohn's disease	0.00368	0.0142	CbGeAlD
Trazodone—HTR2A—smooth muscle tissue—Crohn's disease	0.00368	0.0142	CbGeAlD
Trazodone—Anorexia—Mercaptopurine—Crohn's disease	0.00367	0.00664	CcSEcCtD
Trazodone—CYP3A5—digestive system—Crohn's disease	0.00358	0.0138	CbGeAlD
Trazodone—Abdominal discomfort—Mesalazine—Crohn's disease	0.00352	0.00637	CcSEcCtD
Trazodone—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.00351	0.00634	CcSEcCtD
Trazodone—HRH1—digestive system—Crohn's disease	0.00348	0.0134	CbGeAlD
Trazodone—Pollakiuria—Mesalazine—Crohn's disease	0.00339	0.00614	CcSEcCtD
Trazodone—Photosensitivity reaction—Mesalazine—Crohn's disease	0.00335	0.00607	CcSEcCtD
Trazodone—Decreased appetite—Mercaptopurine—Crohn's disease	0.00335	0.00605	CcSEcCtD
Trazodone—Weight increased—Mesalazine—Crohn's disease	0.00334	0.00605	CcSEcCtD
Trazodone—Weight decreased—Mesalazine—Crohn's disease	0.00332	0.00601	CcSEcCtD
Trazodone—Leukocytosis—Prednisone—Crohn's disease	0.0033	0.00596	CcSEcCtD
Trazodone—Jaundice—Mesalazine—Crohn's disease	0.00319	0.00578	CcSEcCtD
Trazodone—Vasculitis—Prednisone—Crohn's disease	0.00317	0.00574	CcSEcCtD
Trazodone—Sweating—Mesalazine—Crohn's disease	0.00314	0.00568	CcSEcCtD
Trazodone—Haematuria—Mesalazine—Crohn's disease	0.00312	0.00565	CcSEcCtD
Trazodone—HTR2B—lymph node—Crohn's disease	0.00311	0.012	CbGeAlD
Trazodone—Body temperature increased—Mercaptopurine—Crohn's disease	0.00304	0.0055	CcSEcCtD
Trazodone—HTR2A—digestive system—Crohn's disease	0.0029	0.0112	CbGeAlD
Trazodone—Chills—Azathioprine—Crohn's disease	0.0029	0.00524	CcSEcCtD
Trazodone—Arrhythmia—Azathioprine—Crohn's disease	0.00288	0.00522	CcSEcCtD
Trazodone—Alopecia—Azathioprine—Crohn's disease	0.00285	0.00516	CcSEcCtD
Trazodone—Hypersensitivity—Mercaptopurine—Crohn's disease	0.00284	0.00513	CcSEcCtD
Trazodone—Tinnitus—Mesalazine—Crohn's disease	0.00274	0.00496	CcSEcCtD
Trazodone—CYP3A4—digestive system—Crohn's disease	0.00269	0.0104	CbGeAlD
Trazodone—CYP2D6—digestive system—Crohn's disease	0.00265	0.0102	CbGeAlD
Trazodone—Chills—Mesalazine—Crohn's disease	0.00264	0.00477	CcSEcCtD
Trazodone—Diarrhoea—Mercaptopurine—Crohn's disease	0.00263	0.00476	CcSEcCtD
Trazodone—Ill-defined disorder—Azathioprine—Crohn's disease	0.00261	0.00472	CcSEcCtD
Trazodone—Alopecia—Mesalazine—Crohn's disease	0.0026	0.0047	CcSEcCtD
Trazodone—Anaemia—Azathioprine—Crohn's disease	0.0026	0.0047	CcSEcCtD
Trazodone—Malaise—Azathioprine—Crohn's disease	0.00253	0.00458	CcSEcCtD
Trazodone—Flatulence—Mesalazine—Crohn's disease	0.00252	0.00456	CcSEcCtD
Trazodone—Tension—Mesalazine—Crohn's disease	0.00251	0.00454	CcSEcCtD
Trazodone—Dysgeusia—Mesalazine—Crohn's disease	0.00251	0.00453	CcSEcCtD
Trazodone—ABCB1—epithelium—Crohn's disease	0.0025	0.00965	CbGeAlD
Trazodone—Nervousness—Mesalazine—Crohn's disease	0.00249	0.0045	CcSEcCtD
Trazodone—Cardiac failure congestive—Prednisone—Crohn's disease	0.00248	0.00449	CcSEcCtD
Trazodone—Back pain—Mesalazine—Crohn's disease	0.00248	0.00448	CcSEcCtD
Trazodone—Vomiting—Mercaptopurine—Crohn's disease	0.00245	0.00443	CcSEcCtD
Trazodone—Rash—Mercaptopurine—Crohn's disease	0.00243	0.00439	CcSEcCtD
Trazodone—Dermatitis—Mercaptopurine—Crohn's disease	0.00242	0.00439	CcSEcCtD
Trazodone—Vision blurred—Mesalazine—Crohn's disease	0.00241	0.00436	CcSEcCtD
Trazodone—Tremor—Mesalazine—Crohn's disease	0.0024	0.00434	CcSEcCtD
Trazodone—Amnesia—Prednisone—Crohn's disease	0.00239	0.00433	CcSEcCtD
Trazodone—Increased appetite—Prednisone—Crohn's disease	0.00239	0.00433	CcSEcCtD
Trazodone—Arthralgia—Azathioprine—Crohn's disease	0.00239	0.00433	CcSEcCtD
Trazodone—Myalgia—Azathioprine—Crohn's disease	0.00239	0.00433	CcSEcCtD
Trazodone—Ill-defined disorder—Mesalazine—Crohn's disease	0.00238	0.0043	CcSEcCtD
Trazodone—Anaemia—Mesalazine—Crohn's disease	0.00237	0.00428	CcSEcCtD
Trazodone—Discomfort—Azathioprine—Crohn's disease	0.00236	0.00428	CcSEcCtD
Trazodone—Malaise—Mesalazine—Crohn's disease	0.00231	0.00418	CcSEcCtD
Trazodone—Vertigo—Mesalazine—Crohn's disease	0.0023	0.00416	CcSEcCtD
Trazodone—Syncope—Mesalazine—Crohn's disease	0.0023	0.00415	CcSEcCtD
Trazodone—Lethargy—Prednisone—Crohn's disease	0.00229	0.00415	CcSEcCtD
Trazodone—Nausea—Mercaptopurine—Crohn's disease	0.00229	0.00414	CcSEcCtD
Trazodone—Palpitations—Mesalazine—Crohn's disease	0.00226	0.00409	CcSEcCtD
Trazodone—Loss of consciousness—Mesalazine—Crohn's disease	0.00225	0.00407	CcSEcCtD
Trazodone—Hypertension—Mesalazine—Crohn's disease	0.00221	0.004	CcSEcCtD
Trazodone—Psychotic disorder—Prednisone—Crohn's disease	0.0022	0.00397	CcSEcCtD
Trazodone—Arthralgia—Mesalazine—Crohn's disease	0.00218	0.00394	CcSEcCtD
Trazodone—Chest pain—Mesalazine—Crohn's disease	0.00218	0.00394	CcSEcCtD
Trazodone—Myalgia—Mesalazine—Crohn's disease	0.00218	0.00394	CcSEcCtD
Trazodone—Anxiety—Mesalazine—Crohn's disease	0.00217	0.00393	CcSEcCtD
Trazodone—ABCB1—mammalian vulva—Crohn's disease	0.00217	0.00837	CbGeAlD
Trazodone—Discomfort—Mesalazine—Crohn's disease	0.00215	0.00389	CcSEcCtD
Trazodone—Hypotension—Azathioprine—Crohn's disease	0.00214	0.00388	CcSEcCtD
Trazodone—Cardiac arrest—Prednisone—Crohn's disease	0.00214	0.00387	CcSEcCtD
Trazodone—Dry mouth—Mesalazine—Crohn's disease	0.00213	0.00386	CcSEcCtD
Trazodone—Confusional state—Mesalazine—Crohn's disease	0.00211	0.00381	CcSEcCtD
Trazodone—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.00209	0.00378	CcSEcCtD
Trazodone—Oedema—Mesalazine—Crohn's disease	0.00209	0.00378	CcSEcCtD
Trazodone—Shock—Mesalazine—Crohn's disease	0.00206	0.00372	CcSEcCtD
Trazodone—Tachycardia—Mesalazine—Crohn's disease	0.00204	0.00369	CcSEcCtD
Trazodone—Hyperhidrosis—Mesalazine—Crohn's disease	0.00202	0.00365	CcSEcCtD
Trazodone—Anorexia—Mesalazine—Crohn's disease	0.00199	0.0036	CcSEcCtD
Trazodone—HRH1—lymph node—Crohn's disease	0.00199	0.00766	CbGeAlD
Trazodone—Hypotension—Mesalazine—Crohn's disease	0.00195	0.00353	CcSEcCtD
Trazodone—ADRA2A—lymph node—Crohn's disease	0.00195	0.00752	CbGeAlD
Trazodone—ABCB1—lymphoid tissue—Crohn's disease	0.00193	0.00743	CbGeAlD
Trazodone—ABCB1—digestive system—Crohn's disease	0.0019	0.00734	CbGeAlD
Trazodone—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.0019	0.00344	CcSEcCtD
Trazodone—Feeling abnormal—Azathioprine—Crohn's disease	0.00189	0.00342	CcSEcCtD
Trazodone—Insomnia—Mesalazine—Crohn's disease	0.00189	0.00342	CcSEcCtD
Trazodone—Paraesthesia—Mesalazine—Crohn's disease	0.00188	0.00339	CcSEcCtD
Trazodone—Gastrointestinal pain—Azathioprine—Crohn's disease	0.00188	0.00339	CcSEcCtD
Trazodone—Dyspnoea—Mesalazine—Crohn's disease	0.00186	0.00337	CcSEcCtD
Trazodone—Somnolence—Mesalazine—Crohn's disease	0.00186	0.00336	CcSEcCtD
Trazodone—Decreased appetite—Mesalazine—Crohn's disease	0.00182	0.00329	CcSEcCtD
Trazodone—Body temperature increased—Azathioprine—Crohn's disease	0.00181	0.00328	CcSEcCtD
Trazodone—Abdominal pain—Azathioprine—Crohn's disease	0.00181	0.00328	CcSEcCtD
Trazodone—Fatigue—Mesalazine—Crohn's disease	0.0018	0.00326	CcSEcCtD
Trazodone—Erectile dysfunction—Prednisone—Crohn's disease	0.00179	0.00324	CcSEcCtD
Trazodone—Pain—Mesalazine—Crohn's disease	0.00179	0.00323	CcSEcCtD
Trazodone—Constipation—Mesalazine—Crohn's disease	0.00179	0.00323	CcSEcCtD
Trazodone—Weight increased—Prednisone—Crohn's disease	0.00177	0.0032	CcSEcCtD
Trazodone—Weight decreased—Prednisone—Crohn's disease	0.00176	0.00318	CcSEcCtD
Trazodone—Feeling abnormal—Mesalazine—Crohn's disease	0.00172	0.00311	CcSEcCtD
Trazodone—Acute coronary syndrome—Prednisone—Crohn's disease	0.00171	0.00309	CcSEcCtD
Trazodone—Gastrointestinal pain—Mesalazine—Crohn's disease	0.00171	0.00309	CcSEcCtD
Trazodone—Myocardial infarction—Prednisone—Crohn's disease	0.0017	0.00307	CcSEcCtD
Trazodone—Hypersensitivity—Azathioprine—Crohn's disease	0.00169	0.00306	CcSEcCtD
Trazodone—Urticaria—Mesalazine—Crohn's disease	0.00166	0.003	CcSEcCtD
Trazodone—Abdominal pain—Mesalazine—Crohn's disease	0.00165	0.00299	CcSEcCtD
Trazodone—Body temperature increased—Mesalazine—Crohn's disease	0.00165	0.00299	CcSEcCtD
Trazodone—Bradycardia—Prednisone—Crohn's disease	0.00158	0.00287	CcSEcCtD
Trazodone—Diarrhoea—Azathioprine—Crohn's disease	0.00157	0.00284	CcSEcCtD
Trazodone—Hallucination—Prednisone—Crohn's disease	0.00155	0.0028	CcSEcCtD
Trazodone—Hypersensitivity—Mesalazine—Crohn's disease	0.00154	0.00278	CcSEcCtD
Trazodone—Dizziness—Azathioprine—Crohn's disease	0.00152	0.00274	CcSEcCtD
Trazodone—Asthenia—Mesalazine—Crohn's disease	0.0015	0.00271	CcSEcCtD
Trazodone—Pruritus—Mesalazine—Crohn's disease	0.00148	0.00267	CcSEcCtD
Trazodone—Vomiting—Azathioprine—Crohn's disease	0.00146	0.00264	CcSEcCtD
Trazodone—Rash—Azathioprine—Crohn's disease	0.00145	0.00262	CcSEcCtD
Trazodone—Dermatitis—Azathioprine—Crohn's disease	0.00144	0.00261	CcSEcCtD
Trazodone—Flushing—Prednisone—Crohn's disease	0.00144	0.00261	CcSEcCtD
Trazodone—Headache—Azathioprine—Crohn's disease	0.00144	0.0026	CcSEcCtD
Trazodone—Diarrhoea—Mesalazine—Crohn's disease	0.00143	0.00259	CcSEcCtD
Trazodone—Arrhythmia—Prednisone—Crohn's disease	0.00139	0.00251	CcSEcCtD
Trazodone—Dizziness—Mesalazine—Crohn's disease	0.00138	0.0025	CcSEcCtD
Trazodone—Alopecia—Prednisone—Crohn's disease	0.00137	0.00249	CcSEcCtD
Trazodone—Nausea—Azathioprine—Crohn's disease	0.00136	0.00246	CcSEcCtD
Trazodone—Vomiting—Mesalazine—Crohn's disease	0.00133	0.0024	CcSEcCtD
Trazodone—Rash—Mesalazine—Crohn's disease	0.00132	0.00238	CcSEcCtD
Trazodone—Dermatitis—Mesalazine—Crohn's disease	0.00132	0.00238	CcSEcCtD
Trazodone—Headache—Mesalazine—Crohn's disease	0.00131	0.00237	CcSEcCtD
Trazodone—Vision blurred—Prednisone—Crohn's disease	0.00128	0.00231	CcSEcCtD
Trazodone—Ill-defined disorder—Prednisone—Crohn's disease	0.00126	0.00227	CcSEcCtD
Trazodone—Anaemia—Prednisone—Crohn's disease	0.00125	0.00226	CcSEcCtD
Trazodone—Agitation—Prednisone—Crohn's disease	0.00124	0.00225	CcSEcCtD
Trazodone—Nausea—Mesalazine—Crohn's disease	0.00124	0.00224	CcSEcCtD
Trazodone—Malaise—Prednisone—Crohn's disease	0.00122	0.00221	CcSEcCtD
Trazodone—Vertigo—Prednisone—Crohn's disease	0.00122	0.0022	CcSEcCtD
Trazodone—Syncope—Prednisone—Crohn's disease	0.00121	0.0022	CcSEcCtD
Trazodone—Loss of consciousness—Prednisone—Crohn's disease	0.00119	0.00215	CcSEcCtD
Trazodone—Hypertension—Prednisone—Crohn's disease	0.00117	0.00212	CcSEcCtD
Trazodone—Myalgia—Prednisone—Crohn's disease	0.00115	0.00209	CcSEcCtD
Trazodone—Arthralgia—Prednisone—Crohn's disease	0.00115	0.00209	CcSEcCtD
Trazodone—Anxiety—Prednisone—Crohn's disease	0.00115	0.00208	CcSEcCtD
Trazodone—Discomfort—Prednisone—Crohn's disease	0.00114	0.00206	CcSEcCtD
Trazodone—Oedema—Prednisone—Crohn's disease	0.00111	0.002	CcSEcCtD
Trazodone—Shock—Prednisone—Crohn's disease	0.00109	0.00197	CcSEcCtD
Trazodone—ABCB1—lymph node—Crohn's disease	0.00109	0.00419	CbGeAlD
Trazodone—Tachycardia—Prednisone—Crohn's disease	0.00108	0.00195	CcSEcCtD
Trazodone—Hyperhidrosis—Prednisone—Crohn's disease	0.00107	0.00193	CcSEcCtD
Trazodone—Anorexia—Prednisone—Crohn's disease	0.00105	0.00191	CcSEcCtD
Trazodone—Musculoskeletal discomfort—Prednisone—Crohn's disease	0.00101	0.00182	CcSEcCtD
Trazodone—Insomnia—Prednisone—Crohn's disease	0.001	0.00181	CcSEcCtD
Trazodone—Paraesthesia—Prednisone—Crohn's disease	0.000993	0.0018	CcSEcCtD
Trazodone—Decreased appetite—Prednisone—Crohn's disease	0.000961	0.00174	CcSEcCtD
Trazodone—Fatigue—Prednisone—Crohn's disease	0.000953	0.00172	CcSEcCtD
Trazodone—Constipation—Prednisone—Crohn's disease	0.000945	0.00171	CcSEcCtD
Trazodone—Feeling abnormal—Prednisone—Crohn's disease	0.000911	0.00165	CcSEcCtD
Trazodone—Gastrointestinal pain—Prednisone—Crohn's disease	0.000904	0.00163	CcSEcCtD
Trazodone—Urticaria—Prednisone—Crohn's disease	0.000878	0.00159	CcSEcCtD
Trazodone—Abdominal pain—Prednisone—Crohn's disease	0.000874	0.00158	CcSEcCtD
Trazodone—Body temperature increased—Prednisone—Crohn's disease	0.000874	0.00158	CcSEcCtD
Trazodone—Hypersensitivity—Prednisone—Crohn's disease	0.000814	0.00147	CcSEcCtD
Trazodone—Asthenia—Prednisone—Crohn's disease	0.000793	0.00143	CcSEcCtD
Trazodone—Pruritus—Prednisone—Crohn's disease	0.000782	0.00141	CcSEcCtD
Trazodone—Diarrhoea—Prednisone—Crohn's disease	0.000756	0.00137	CcSEcCtD
Trazodone—Dizziness—Prednisone—Crohn's disease	0.000731	0.00132	CcSEcCtD
Trazodone—Vomiting—Prednisone—Crohn's disease	0.000703	0.00127	CcSEcCtD
Trazodone—Rash—Prednisone—Crohn's disease	0.000697	0.00126	CcSEcCtD
Trazodone—Dermatitis—Prednisone—Crohn's disease	0.000696	0.00126	CcSEcCtD
Trazodone—Headache—Prednisone—Crohn's disease	0.000692	0.00125	CcSEcCtD
Trazodone—Nausea—Prednisone—Crohn's disease	0.000657	0.00119	CcSEcCtD
Trazodone—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	0.000123	0.000655	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—CCR9—Crohn's disease	0.000123	0.000655	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—CCR9—Crohn's disease	0.000123	0.000653	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—SEL1L—Crohn's disease	0.000122	0.000651	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—PLA2G4F—Crohn's disease	0.000122	0.00065	CbGpPWpGaD
Trazodone—ADRA2A—GPCR downstream signaling—PTGER4—Crohn's disease	0.000122	0.000647	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—PTGER4—Crohn's disease	0.000121	0.000646	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—PTGER4—Crohn's disease	0.000121	0.000645	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—CCR9—Crohn's disease	0.00012	0.000641	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—IL3—Crohn's disease	0.00012	0.000637	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—IL3—Crohn's disease	0.000119	0.000634	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—PTGER4—Crohn's disease	0.000119	0.000633	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—FADS1—Crohn's disease	0.000117	0.000623	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—CCR6—Crohn's disease	0.000116	0.000619	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—RASGRP1—Crohn's disease	0.000116	0.000616	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—RASGRP1—Crohn's disease	0.000115	0.000613	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—PLA2G4F—Crohn's disease	0.000115	0.000612	CbGpPWpGaD
Trazodone—ADRA2A—Hemostasis—IL2RA—Crohn's disease	0.000115	0.000611	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—GPR65—Crohn's disease	0.000114	0.000609	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—GPR65—Crohn's disease	0.000114	0.000607	CbGpPWpGaD
Trazodone—HTR2A—GPCR downstream signaling—IL3—Crohn's disease	0.000114	0.000606	CbGpPWpGaD
Trazodone—HTR2B—GPCR downstream signaling—IL2RA—Crohn's disease	0.000114	0.000606	CbGpPWpGaD
Trazodone—HTR2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000114	0.000605	CbGpPWpGaD
Trazodone—HRH1—GPCR downstream signaling—IL3—Crohn's disease	0.000114	0.000605	CbGpPWpGaD
Trazodone—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000113	0.000604	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—GPR65—Crohn's disease	0.000112	0.000596	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—CCR9—Crohn's disease	0.000112	0.000596	CbGpPWpGaD
Trazodone—ADRA1A—GPCR downstream signaling—IL3—Crohn's disease	0.000111	0.000594	CbGpPWpGaD
Trazodone—HTR2A—SIDS Susceptibility Pathways—IL6—Crohn's disease	0.000111	0.000594	CbGpPWpGaD
Trazodone—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000111	0.000593	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—PTGER4—Crohn's disease	0.00011	0.000588	CbGpPWpGaD
Trazodone—HTR2A—GPCR downstream signaling—RASGRP1—Crohn's disease	0.00011	0.000586	CbGpPWpGaD
Trazodone—HRH1—GPCR downstream signaling—RASGRP1—Crohn's disease	0.00011	0.000585	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—GPX4—Crohn's disease	0.00011	0.000583	CbGpPWpGaD
Trazodone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	0.00011	0.000583	CbGpPWpGaD
Trazodone—ADRA1A—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000108	0.000574	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—FADS1—Crohn's disease	0.000107	0.00057	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—GCKR—Crohn's disease	0.000106	0.000563	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—RBX1—Crohn's disease	0.000105	0.00056	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—GPR65—Crohn's disease	0.000104	0.000554	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—MTMR3—Crohn's disease	0.000104	0.000553	CbGpPWpGaD
Trazodone—ADRA2A—GPCR downstream signaling—IL3—Crohn's disease	0.000104	0.000551	CbGpPWpGaD
Trazodone—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000103	0.000551	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—IL3—Crohn's disease	0.000103	0.00055	CbGpPWpGaD
Trazodone—HTR2B—Signaling by GPCR—IL2RA—Crohn's disease	0.000103	0.00055	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—IL3—Crohn's disease	0.000103	0.000549	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—PTGER4—Crohn's disease	0.000102	0.000545	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—IL3—Crohn's disease	0.000101	0.000539	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—GPX4—Crohn's disease	0.0001	0.000534	CbGpPWpGaD
Trazodone—HTR1A—GPCR ligand binding—CXCL8—Crohn's disease	0.0001	0.000534	CbGpPWpGaD
Trazodone—ADRA2A—GPCR downstream signaling—RASGRP1—Crohn's disease	0.0001	0.000533	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—RASGRP1—Crohn's disease	0.0001	0.000532	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—RASGRP1—Crohn's disease	9.98e-05	0.000531	CbGpPWpGaD
Trazodone—HTR2C—GPCR ligand binding—CXCL8—Crohn's disease	9.97e-05	0.000531	CbGpPWpGaD
Trazodone—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	9.93e-05	0.000529	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—RASGRP1—Crohn's disease	9.79e-05	0.000521	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—MTMR3—Crohn's disease	9.78e-05	0.000521	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—GCKR—Crohn's disease	9.69e-05	0.000516	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—CCR6—Crohn's disease	9.43e-05	0.000502	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—IL3—Crohn's disease	9.41e-05	0.000501	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—CCR6—Crohn's disease	9.38e-05	0.000499	CbGpPWpGaD
Trazodone—HTR1A—GPCR downstream signaling—IL2RA—Crohn's disease	9.23e-05	0.000492	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—UBE2D1—Crohn's disease	9.22e-05	0.000491	CbGpPWpGaD
Trazodone—HTR2C—GPCR downstream signaling—IL2RA—Crohn's disease	9.19e-05	0.000489	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—RASGRP1—Crohn's disease	9.1e-05	0.000484	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—RIPK2—Crohn's disease	8.94e-05	0.000476	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—IL3—Crohn's disease	8.72e-05	0.000464	CbGpPWpGaD
Trazodone—HTR2A—GPCR ligand binding—CXCL8—Crohn's disease	8.66e-05	0.000461	CbGpPWpGaD
Trazodone—HRH1—GPCR ligand binding—CXCL8—Crohn's disease	8.64e-05	0.00046	CbGpPWpGaD
Trazodone—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	8.63e-05	0.000459	CbGpPWpGaD
Trazodone—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	8.61e-05	0.000458	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—RBX1—Crohn's disease	8.53e-05	0.000454	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—RBX1—Crohn's disease	8.48e-05	0.000452	CbGpPWpGaD
Trazodone—ADRA1A—GPCR ligand binding—CXCL8—Crohn's disease	8.48e-05	0.000451	CbGpPWpGaD
Trazodone—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	8.45e-05	0.00045	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—RASGRP1—Crohn's disease	8.43e-05	0.000449	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—IL2RA—Crohn's disease	8.38e-05	0.000446	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—IL2RA—Crohn's disease	8.34e-05	0.000444	CbGpPWpGaD
Trazodone—ADRA2A—Hemostasis—ALB—Crohn's disease	8.3e-05	0.000442	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—PTGER4—Crohn's disease	8.3e-05	0.000442	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—PTGER4—Crohn's disease	8.26e-05	0.00044	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—CCR6—Crohn's disease	8.15e-05	0.000434	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—CCR6—Crohn's disease	8.13e-05	0.000433	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—FADS1—Crohn's disease	8.09e-05	0.00043	CbGpPWpGaD
Trazodone—HTR2A—GPCR downstream signaling—IL2RA—Crohn's disease	7.98e-05	0.000425	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—CCR6—Crohn's disease	7.98e-05	0.000425	CbGpPWpGaD
Trazodone—HRH1—GPCR downstream signaling—IL2RA—Crohn's disease	7.96e-05	0.000424	CbGpPWpGaD
Trazodone—ADRA2A—GPCR ligand binding—CXCL8—Crohn's disease	7.88e-05	0.000419	CbGpPWpGaD
Trazodone—ADRA1A—GPCR downstream signaling—IL2RA—Crohn's disease	7.81e-05	0.000416	CbGpPWpGaD
Trazodone—ADRA2A—Hemostasis—JAK2—Crohn's disease	7.72e-05	0.000411	CbGpPWpGaD
Trazodone—HTR2B—GPCR downstream signaling—JAK2—Crohn's disease	7.65e-05	0.000407	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—SOCS1—Crohn's disease	7.64e-05	0.000407	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—FADS1—Crohn's disease	7.62e-05	0.000406	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—GPX4—Crohn's disease	7.57e-05	0.000403	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—PLA2G4F—Crohn's disease	7.52e-05	0.0004	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—UBE2D1—Crohn's disease	7.48e-05	0.000398	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—UBE2D1—Crohn's disease	7.44e-05	0.000396	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—CCR6—Crohn's disease	7.41e-05	0.000395	CbGpPWpGaD
Trazodone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	7.39e-05	0.000394	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—RBX1—Crohn's disease	7.37e-05	0.000392	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—RBX1—Crohn's disease	7.35e-05	0.000391	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—GCKR—Crohn's disease	7.31e-05	0.000389	CbGpPWpGaD
Trazodone—HTR2B—Signaling by GPCR—TYK2—Crohn's disease	7.28e-05	0.000388	CbGpPWpGaD
Trazodone—ADRA2A—GPCR downstream signaling—IL2RA—Crohn's disease	7.26e-05	0.000386	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—RIPK2—Crohn's disease	7.25e-05	0.000386	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—IL2RA—Crohn's disease	7.24e-05	0.000386	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—IL2RA—Crohn's disease	7.23e-05	0.000385	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—RIPK2—Crohn's disease	7.21e-05	0.000384	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—RBX1—Crohn's disease	7.21e-05	0.000384	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—PTGER4—Crohn's disease	7.17e-05	0.000382	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—PTGER4—Crohn's disease	7.16e-05	0.000381	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—GPX4—Crohn's disease	7.14e-05	0.00038	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—IL2RA—Crohn's disease	7.09e-05	0.000378	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—IL3—Crohn's disease	7.07e-05	0.000376	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—IL3—Crohn's disease	7.03e-05	0.000374	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—PTGER4—Crohn's disease	7.02e-05	0.000374	CbGpPWpGaD
Trazodone—HTR2B—GPCR downstream signaling—CXCL8—Crohn's disease	6.98e-05	0.000372	CbGpPWpGaD
Trazodone—HTR2B—Signaling by GPCR—JAK2—Crohn's disease	6.95e-05	0.00037	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—GCKR—Crohn's disease	6.89e-05	0.000367	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—RASGRP1—Crohn's disease	6.84e-05	0.000364	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—RASGRP1—Crohn's disease	6.8e-05	0.000362	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—RBX1—Crohn's disease	6.7e-05	0.000357	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—SMAD3—Crohn's disease	6.6e-05	0.000351	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—IL2RA—Crohn's disease	6.59e-05	0.000351	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—PTGER4—Crohn's disease	6.52e-05	0.000347	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—UBE2D1—Crohn's disease	6.46e-05	0.000344	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—UBE2D1—Crohn's disease	6.45e-05	0.000343	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—MTMR3—Crohn's disease	6.4e-05	0.00034	CbGpPWpGaD
Trazodone—HTR2B—Signaling by GPCR—CXCL8—Crohn's disease	6.34e-05	0.000338	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—UBE2D1—Crohn's disease	6.33e-05	0.000337	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—RIPK2—Crohn's disease	6.26e-05	0.000333	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—RIPK2—Crohn's disease	6.25e-05	0.000333	CbGpPWpGaD
Trazodone—HTR1A—GPCR downstream signaling—JAK2—Crohn's disease	6.21e-05	0.00033	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—SOCS1—Crohn's disease	6.2e-05	0.00033	CbGpPWpGaD
Trazodone—HTR2C—GPCR downstream signaling—JAK2—Crohn's disease	6.17e-05	0.000329	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—SOCS1—Crohn's disease	6.16e-05	0.000328	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—RIPK2—Crohn's disease	6.13e-05	0.000326	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—IL3—Crohn's disease	6.11e-05	0.000325	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—IL2RA—Crohn's disease	6.11e-05	0.000325	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—IL3—Crohn's disease	6.1e-05	0.000324	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—IL3—Crohn's disease	5.98e-05	0.000318	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—RASGRP1—Crohn's disease	5.91e-05	0.000315	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—TYK2—Crohn's disease	5.91e-05	0.000314	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—RASGRP1—Crohn's disease	5.9e-05	0.000314	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—TYK2—Crohn's disease	5.88e-05	0.000313	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—UBE2D1—Crohn's disease	5.88e-05	0.000313	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—RASGRP1—Crohn's disease	5.79e-05	0.000308	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—RIPK2—Crohn's disease	5.7e-05	0.000303	CbGpPWpGaD
Trazodone—HTR1A—GPCR downstream signaling—CXCL8—Crohn's disease	5.66e-05	0.000302	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—JAK2—Crohn's disease	5.64e-05	0.0003	CbGpPWpGaD
Trazodone—HTR2C—GPCR downstream signaling—CXCL8—Crohn's disease	5.63e-05	0.0003	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—JAK2—Crohn's disease	5.61e-05	0.000298	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—IL3—Crohn's disease	5.56e-05	0.000296	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—RASGRP1—Crohn's disease	5.38e-05	0.000286	CbGpPWpGaD
Trazodone—HTR2A—GPCR downstream signaling—JAK2—Crohn's disease	5.36e-05	0.000285	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—SOCS1—Crohn's disease	5.35e-05	0.000285	CbGpPWpGaD
Trazodone—HRH1—GPCR downstream signaling—JAK2—Crohn's disease	5.35e-05	0.000285	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—SMAD3—Crohn's disease	5.35e-05	0.000285	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—SOCS1—Crohn's disease	5.34e-05	0.000284	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—SMAD3—Crohn's disease	5.32e-05	0.000283	CbGpPWpGaD
Trazodone—ADRA1A—GPCR downstream signaling—JAK2—Crohn's disease	5.25e-05	0.000279	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—SOCS1—Crohn's disease	5.24e-05	0.000279	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—CXCL8—Crohn's disease	5.14e-05	0.000274	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—CXCL8—Crohn's disease	5.12e-05	0.000272	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—TYK2—Crohn's disease	5.1e-05	0.000272	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—TYK2—Crohn's disease	5.09e-05	0.000271	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—TYK2—Crohn's disease	5e-05	0.000266	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—FADS1—Crohn's disease	4.98e-05	0.000265	CbGpPWpGaD
Trazodone—ABCB1—Transmembrane transport of small molecules—ALB—Crohn's disease	4.97e-05	0.000265	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—IL2RA—Crohn's disease	4.95e-05	0.000264	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—IL2RA—Crohn's disease	4.93e-05	0.000262	CbGpPWpGaD
Trazodone—HTR2A—GPCR downstream signaling—CXCL8—Crohn's disease	4.89e-05	0.00026	CbGpPWpGaD
Trazodone—HRH1—GPCR downstream signaling—CXCL8—Crohn's disease	4.88e-05	0.00026	CbGpPWpGaD
Trazodone—ADRA2A—GPCR downstream signaling—JAK2—Crohn's disease	4.88e-05	0.00026	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—SOCS1—Crohn's disease	4.87e-05	0.000259	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—JAK2—Crohn's disease	4.87e-05	0.000259	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—JAK2—Crohn's disease	4.86e-05	0.000259	CbGpPWpGaD
Trazodone—ADRA1A—GPCR downstream signaling—CXCL8—Crohn's disease	4.79e-05	0.000255	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—JAK2—Crohn's disease	4.77e-05	0.000254	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—GPX4—Crohn's disease	4.67e-05	0.000248	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—TYK2—Crohn's disease	4.64e-05	0.000247	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—SMAD3—Crohn's disease	4.62e-05	0.000246	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—SMAD3—Crohn's disease	4.61e-05	0.000245	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—SMAD3—Crohn's disease	4.53e-05	0.000241	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—GCKR—Crohn's disease	4.51e-05	0.00024	CbGpPWpGaD
Trazodone—ADRA2A—GPCR downstream signaling—CXCL8—Crohn's disease	4.45e-05	0.000237	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—CXCL8—Crohn's disease	4.44e-05	0.000237	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—CXCL8—Crohn's disease	4.43e-05	0.000236	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—JAK2—Crohn's disease	4.43e-05	0.000236	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—CXCL8—Crohn's disease	4.35e-05	0.000232	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—TYK2—Crohn's disease	4.3e-05	0.000229	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—IL2RA—Crohn's disease	4.28e-05	0.000228	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—IL2RA—Crohn's disease	4.27e-05	0.000227	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—ALB—Crohn's disease	4.27e-05	0.000227	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—SMAD3—Crohn's disease	4.2e-05	0.000224	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—IL2RA—Crohn's disease	4.19e-05	0.000223	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—JAK2—Crohn's disease	4.11e-05	0.000219	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—CXCL8—Crohn's disease	4.04e-05	0.000215	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—IL2RA—Crohn's disease	3.89e-05	0.000207	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—CXCL8—Crohn's disease	3.75e-05	0.000199	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—PTGS2—Crohn's disease	3.73e-05	0.000199	CbGpPWpGaD
Trazodone—HTR2B—Signaling by GPCR—IL6—Crohn's disease	3.56e-05	0.00019	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—TYK2—Crohn's disease	3.49e-05	0.000186	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—TYK2—Crohn's disease	3.47e-05	0.000185	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—ALB—Crohn's disease	3.37e-05	0.000179	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—JAK2—Crohn's disease	3.33e-05	0.000177	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—JAK2—Crohn's disease	3.31e-05	0.000176	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—ALB—Crohn's disease	3.08e-05	0.000164	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—CXCL8—Crohn's disease	3.04e-05	0.000162	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—CXCL8—Crohn's disease	3.02e-05	0.000161	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—TYK2—Crohn's disease	3.01e-05	0.00016	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—STAT3—Crohn's disease	3.01e-05	0.00016	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—TYK2—Crohn's disease	3.01e-05	0.00016	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—TYK2—Crohn's disease	2.95e-05	0.000157	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—PTGS2—Crohn's disease	2.94e-05	0.000157	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—IL6—Crohn's disease	2.89e-05	0.000154	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—JAK2—Crohn's disease	2.88e-05	0.000153	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—IL6—Crohn's disease	2.87e-05	0.000153	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—JAK2—Crohn's disease	2.87e-05	0.000153	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—JAK2—Crohn's disease	2.82e-05	0.00015	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—TYK2—Crohn's disease	2.74e-05	0.000146	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—PTGS2—Crohn's disease	2.7e-05	0.000144	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—CXCL8—Crohn's disease	2.62e-05	0.00014	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—CXCL8—Crohn's disease	2.62e-05	0.000139	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—JAK2—Crohn's disease	2.62e-05	0.000139	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—CXCL8—Crohn's disease	2.57e-05	0.000137	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—IL6—Crohn's disease	2.5e-05	0.000133	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—IL6—Crohn's disease	2.49e-05	0.000133	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—IL6—Crohn's disease	2.44e-05	0.00013	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—STAT3—Crohn's disease	2.44e-05	0.00013	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—STAT3—Crohn's disease	2.43e-05	0.000129	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—CXCL8—Crohn's disease	2.39e-05	0.000127	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—ALB—Crohn's disease	2.33e-05	0.000124	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—IL6—Crohn's disease	2.27e-05	0.000121	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—ALB—Crohn's disease	2.19e-05	0.000117	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—STAT3—Crohn's disease	2.11e-05	0.000112	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—STAT3—Crohn's disease	2.11e-05	0.000112	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—IL6—Crohn's disease	2.1e-05	0.000112	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—STAT3—Crohn's disease	2.07e-05	0.00011	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—PTGS2—Crohn's disease	2.04e-05	0.000108	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—STAT3—Crohn's disease	1.92e-05	0.000102	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—PTGS2—Crohn's disease	1.92e-05	0.000102	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—IL6—Crohn's disease	1.71e-05	9.09e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—IL6—Crohn's disease	1.7e-05	9.04e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—IL6—Crohn's disease	1.47e-05	7.85e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—IL6—Crohn's disease	1.47e-05	7.83e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—IL6—Crohn's disease	1.44e-05	7.69e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—ALB—Crohn's disease	1.43e-05	7.63e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—IL6—Crohn's disease	1.34e-05	7.14e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—PTGS2—Crohn's disease	1.25e-05	6.68e-05	CbGpPWpGaD
